Volume 29, Issue 4 pp. 445-452

Chronic migraine and medication overuse headache: clarifying the current International Headache Society classification criteria

C Sun-Edelstein

C Sun-Edelstein

The New York Headache Center, New York, NY,

Search for more papers by this author
ME Bigal

ME Bigal

Merck Research Laboratories, Whitehouse Station, NJ, and

Search for more papers by this author
AM Rapoport

AM Rapoport

The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Search for more papers by this author
First published: 06 March 2009
Citations: 5
Dr Christina Sun-Edelstein MD, The New York Headache Center, 30 East 76th Street, New York, NY 10021 USA. Tel. + 1-212-794-3550, fax + 1-212-794-0591, e-mail [email protected]

Abstract

Despite the recent advances in the understanding and classification of the chronic daily headaches, considerable controversy still exists regarding the classification of individual headaches, including chronic migraine (CM) and medication overuse headache (MOH). The original criteria, published in 2004, were difficult to apply to most patients with these disorders and were subsequently revised, resulting in broader clinical applicability. Nonetheless, they remain a topic of debate, and the revisions to the criteria have further added to the confusion. Even some prominent headache specialists are unsure which criteria to use. We aimed to explain the nature of the controversies surrounding the entities of CM and MOH. A clinical case will be used to illustrate some of the problems faced by clinicians in diagnosing patients with chronic daily headache.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.